You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Myeloid, Acute

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

Not yet recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Subcutaneous azacitidine
  • Oral decitabine/cedazuridine
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
May 29, 2023

Leukemia, Myeloid, Acute Trial in Chengdu (Chidamide)

Recruiting
  • Leukemia, Myeloid, Acute
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Dec 27, 2022

Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Suzhou, Jiangsu, China
    Qiu Huiying
Mar 28, 2023

GilteRInf 2022 Study (Gilteritinib Related Infections)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Roma, RM, Italy
    Maria Ilaria Del Principe
Mar 17, 2023

AML Trial in Guanzhou (CLAG)

Not yet recruiting
  • AML
  • CLAG
  • Guanzhou, Guangdong, China
  • +1 more
May 16, 2023

Leukemia, Myeloid, Acute Trial (CD33KO-HSPC; CART33)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • CD33KO-HSPC; CART33
  • (no location specified)
Jul 13, 2023

Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

Recruiting
  • Refractory/Relapse Acute Myeloid Leukemia
  • Kunming, Yunnan, China
    Department of Hematology,920th Hospital of Joint Logistic Suppor
Mar 28, 2023

Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)

Recruiting
  • Acute Myeloid Leukemia, Adult
  • cladribine + homoharringtonine + cytarabine
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of Med
Jun 13, 2023

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • +2 more
  • CPI 613
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
May 10, 2023

Relapsed/Refractory Acute Myeloid Leukemia Trial in Hangzhou (B7-H3 target, CAR gene modified gdT cell injection)

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • B7-H3 target, CAR gene modified gdT cell injection
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital， Zhejiang University School of Med
Feb 15, 2023

Mold Infections in Children During Leukemia Treatment

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Acute Lymphoblastic Leukemia
    • Odense, Denmark
      Rasmus Møller Duus
    Mar 7, 2023

    Acute Myeloid Leukemia Trial in Fuzhou (CLL1/+CD33 CAR-T)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • CLL1/+CD33 CAR-T
    • Fuzhou, Fujian, China
      Fujian Provincial Children's Hospital
    Jul 10, 2023

    Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • (no location specified)
    Sep 18, 2023

    Acute Myeloid Leukemia Trial in Cincinnati (CIML-NK Cells)

    Recruiting
    • Acute Myeloid Leukemia
    • CIML-NK Cells
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Jan 4, 2023

    Acute Myeloid Leukemia Trial in Kunming (CLL1 and CD38 dual-target CAR-T injection)

    Recruiting
    • Acute Myeloid Leukemia
    • CLL1 and CD38 dual-target CAR-T injection
    • Kunming, Yunnan, China
      920th Hospital of Joint LogisticsSupport Force of People's Liber
    Oct 26, 2023

    Venetoclax Plasma Concentration and Remission in Acute Myeloid

    Not yet recruiting
    • Adult Acute Myeloid Leukemia
    • Blood sampling for venetoclax drug dosage (venous puncture)
    • (no location specified)
    Sep 13, 2023

    Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Secondary Leukemia
    • Multiomic characterization
    • In vitro drug screening
    • (no location specified)
    Aug 28, 2023

    Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

    Recruiting
    • Relapsed or Refractory Acute Myeloid Leukemia
    • Taiyuan, Shanxi, China
      Tao Wang
    Feb 9, 2023

    Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Miami, Florida
      University of Miami
    Dec 22, 2022

    AML, Adult Trial (STI-8591)

    Not yet recruiting
    • AML, Adult
    • (no location specified)
    Jul 12, 2023

    Acute Myeloid Leukemia Trial in Beijing (azacytidine;cytarabine;aclamycin;Chidamide;venetoclax;granulocyte)

    Recruiting
    • Acute Myeloid Leukemia
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Dec 13, 2022

    Relapsed/Refractory Acute Myeloid Leukemia Trial in Hefei (gdT cell injection targeting B7-H3 chimeric antigen receptor)

    Recruiting
    • Relapsed/Refractory Acute Myeloid Leukemia
    • gdT cell injection targeting B7-H3 chimeric antigen receptor
    • Hefei, Anhui, China
      PersonGen Anke Cellular Therapeutice Co., Ltd.
    Jan 31, 2023

    Acute Myeloid Leukemia Trial (NK cells, Talazoparib 1 MG [Talzenna])

    Not yet recruiting
    • Acute Myeloid Leukemia
    • NK cells
    • Talazoparib 1 MG [Talzenna]
    • (no location specified)
    Jan 9, 2023

    Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

    Recruiting
    • Acute Myeloid Leukemia
    • Venclexta 100 MG Oral Tablet
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Jun 11, 2023